Product Detail


Share to:
facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button

Cas No. 1168150-46-6, (3E)-2,3-Dihydro-3-(methoxyphenylmethylene)-2-oxo-1H-indole-6-carboxylic acid methyl ester

  • 1168150-46-6

  • C18H15NO4

  • 309.3

  • 1.273±0.06

  • Light Yellow

  • Anticancer

  • Nintedanib

  • 12/7/2029 (Nintedanib)

  • RTKs, nRTKs



Nintedanib is reshaping the treatment landscape of idiopathic pulmonary fibrosis, offering a much-needed therapeutic option for patients with this debilitating lung disease. With our reliable intermediates, streamline the manufacturing process and ensure a steady supply of this transformative medication. Join us in pioneering the fight against pulmonary fibrosis, improving patients' quality of life and driving innovative advancements in respiratory care. Embrace Nintedanib and make a lasting impact in the field of pulmonary therapeutics.